The AE Alliance is pleased to announce its inauguration of a Seed Grant Program to support research focused on the diagnosis, management, and outcomes of individuals with AE, funded by AE Alliance.
In its inaugural year, multiple grants of $10,000 will be awarded. While applications pertaining to clinical, basic, and/or translational research will be considered, proposed studies must have direct implications for patients with AE.
Application Deadline: April 5, 2021
Award Notification: Late May 2021
Application (four pages maximum), including background, specific aims, impact/relevance, research plan, and any supporting preliminary data/figures. Please explicitly discuss the implications that the study will have for patients with AE.
Applicant’s NIH Biosketch
Mentor’s NIH Biosketch (if the applicant is a student, trainee, post-doc, and/or junior faculty)
Please submit all application documents (as PDFs) prior to the deadline by email to [email protected]. Please include in the email the applicant’s full name, academic affiliation, and email address.
Applications will be reviewed by the AE Alliance’s Special Grants Review Committee, which includes members of the Research Sub-Committee of the Medical Advisory Board and business experts appointed by the AE Alliance. Applications will be scored based on their scientific rigor, impact, and alignment with the AE Alliance’s Mission (as noted above). Committee members with a potential conflict of interest with the applicant or project will recuse themselves from review of that application. Following review of all applications, the committee will make a recommendation to the governing board of the AE Alliance, which will have the final approval for funding.
Caterri Woodrum, email: [email protected]
The application deadline has closed and we will be announcing the awards mid May